↓ Skip to main content

Dove Medical Press

Article Metrics

Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers

Overview of attention for article published in Vascular Health and Risk Management, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
1 tweeter
patent
7 patents

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
95 Mendeley
Title
Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
Published in
Vascular Health and Risk Management, November 2012
DOI 10.2147/vhrm.s37969
Pubmed ID
Authors

Steve Brunell, Peter Toth, Ramirez, Cobble, Chilton, Chiquette

Abstract

Cyslipidemia and type 2 diabetes are two of the most significant risk factors for the development of cardiovascular disease. Measurement of lipoprotein subclasses provides important information about derangements in lipid metabolism and helps refine cardiovascular risk assessment. Exenatide, a glucagon-like peptide 1 receptor agonist, improved glycemic control, obesity, hypertension, and dyslipidemia in patients with type 2 diabetes in clinical trials.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Greece 1 1%
Denmark 1 1%
Poland 1 1%
Unknown 91 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 18%
Researcher 14 15%
Student > Bachelor 12 13%
Student > Postgraduate 10 11%
Other 8 8%
Other 18 19%
Unknown 16 17%
Readers by discipline Count As %
Medicine and Dentistry 43 45%
Pharmacology, Toxicology and Pharmaceutical Science 10 11%
Agricultural and Biological Sciences 8 8%
Nursing and Health Professions 6 6%
Biochemistry, Genetics and Molecular Biology 2 2%
Other 6 6%
Unknown 20 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2021.
All research outputs
#3,413,405
of 19,001,205 outputs
Outputs from Vascular Health and Risk Management
#108
of 677 outputs
Outputs of similar age
#44,972
of 272,233 outputs
Outputs of similar age from Vascular Health and Risk Management
#4
of 11 outputs
Altmetric has tracked 19,001,205 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 677 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 272,233 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.